957346-62-2 Usage
Uses
Used in Organic Synthesis:
5-Bromothiazole-2-carboxylic acid is used as a building block in organic synthesis for the introduction of the thiazole ring into various molecules, contributing to the development of new compounds with potential applications in various industries.
Used in Pharmaceutical Production:
5-Bromothiazole-2-carboxylic acid is used as an intermediate in the production of pharmaceuticals, playing a crucial role in the synthesis of drugs with therapeutic properties.
Used in Agrochemical Production:
5-Bromothiazole-2-carboxylic acid is also used as an intermediate in the production of agrochemicals, contributing to the development of effective products for agricultural applications.
Used in Antiviral and Antimicrobial Research:
5-Bromothiazole-2-carboxylic acid has been researched for its potential antiviral and antimicrobial properties, indicating its potential use in the development of treatments for viral and bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 957346-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,3,4 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 957346-62:
(8*9)+(7*5)+(6*7)+(5*3)+(4*4)+(3*6)+(2*6)+(1*2)=212
212 % 10 = 2
So 957346-62-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H2BrNO2S/c5-2-1-6-3(9-2)4(7)8/h1H,(H,7,8)
957346-62-2Relevant articles and documents
3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I
-
Page/Page column 36; 53; 54, (2015/11/16)
The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II
-
Page/Page column 30, (2015/12/11)
The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors exhibiting a pronounced CatK-inhibition, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
